Vidrio-Velázquez M

Language: Spanish
References: 11
Page: 34-36
PDF size: 59.82 Kb.

Text Extraction

No abstract

REFERENCES

1. Grossmann M. Low testosterone in men with type 2 diabetes: Significance and treatment. J Clin Endocrinol Metab 2011; 96: 2341–2353.

2. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68–75.

3. Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly swedish men. J Clin Endocrinol Metab 2010; 95: 4406–4414.

4. Krasnoff JB, Basaria S, Pencina MJ, Jasuja GK, Vasan RS, Ulloor J et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham offspring study. J Clin Endocrinol Metab 2010; 95: 2790–2799.

5. Wu FC. Caveat emptor: Does testosterone treatment reduce mortality in men? J Clin Endocrinol Metab 2012; 97: 1884-1886.

6. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Endogenous testosterone and mortality in men: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 3007–3019.

7. Anawalt BD. Guidelines for testosterone therapy for men: How to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab 2010; 96: 2614-2617.

8. Snyder PJ. Might testosterone actually reduce mortality? J Clin Endocrinol Metab 2008; 93: 32–33.

9. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012; 97: 2050–2058.

10. Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren Ö, Mellström D et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 2009; 94: 2482–2488.

11. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109–122.